Alka Shrikhande

2.1k total citations
30 papers, 821 citations indexed

About

Alka Shrikhande is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Alka Shrikhande has authored 30 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Hematology. Recurrent topics in Alka Shrikhande's work include Receptor Mechanisms and Signaling (7 papers), Hemoglobinopathies and Related Disorders (5 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Alka Shrikhande is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Hemoglobinopathies and Related Disorders (5 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Alka Shrikhande collaborates with scholars based in United States, India and Netherlands. Alka Shrikhande's co-authors include Gary L. Davis, Lorraine A. Lebel, Christopher J. Schmidt, Sheryl A. McCarthy, Judith A. Siuciak, John F. Harms, Frank S. Menniti, Douglas S. Chapin, Stephen K.-F. Wong and Leslie K. Chambers and has published in prestigious journals such as Biochemical Journal, FEBS Letters and The Journal of Urology.

In The Last Decade

Alka Shrikhande

28 papers receiving 785 citations

Peers

Alka Shrikhande
Terri Cummons United States
Lucien Gazi Switzerland
Jason P. Riley United States
Rhonda L. Carter United States
P.A. Robson France
Boonlert Cheewatrakoolpong United States
Masahito Ogasawara Japan
Marina Stolina United States
Minh Vu Chuong Nguyen France
Naj Sharif United States
Terri Cummons United States
Alka Shrikhande
Citations per year, relative to Alka Shrikhande Alka Shrikhande (= 1×) peers Terri Cummons

Countries citing papers authored by Alka Shrikhande

Since Specialization
Citations

This map shows the geographic impact of Alka Shrikhande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alka Shrikhande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alka Shrikhande more than expected).

Fields of papers citing papers by Alka Shrikhande

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alka Shrikhande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alka Shrikhande. The network helps show where Alka Shrikhande may publish in the future.

Co-authorship network of co-authors of Alka Shrikhande

This figure shows the co-authorship network connecting the top 25 collaborators of Alka Shrikhande. A scholar is included among the top collaborators of Alka Shrikhande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alka Shrikhande. Alka Shrikhande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shrikhande, Alka, et al.. (2020). Prevalence of Cholelithiasis in Sickle Cell Hemoglobinopathy, Central Indian Scenario. International Journal of Scientific and Research Publications. 10(1). p9740–p9740.
2.
Shrikhande, Alka, et al.. (2015). MULTIPLE CUTANEOUS PILOLEIOMYOMA WITH UTERINE FIBROIDS (REED’S SYNDROME): A RARE CASE REPORT. Clinical & Biomedical Research. 1(4). 66–69. 1 indexed citations
3.
Shrivastava, Alankar, et al.. (2014). Prenatal Diagnosis of Sickle Cell Disease by the Technique of PCR. Indian Journal of Hematology and Blood Transfusion. 31(2). 233–241. 16 indexed citations
4.
Rollema, Hans, Alka Shrikhande, J.W. Coe, et al.. (2010). Pre‐clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. British Journal of Pharmacology. 160(2). 334–345. 131 indexed citations
5.
Nadanaciva, Sashi, Keith Dillman, David F. Gebhard, Alka Shrikhande, & Yvonne Will. (2010). High-Content Screening for Compounds That Affect mtDNA-Encoded Protein Levels in Eukaryotic Cells. SLAS DISCOVERY. 15(8). 937–948. 23 indexed citations
6.
Rollema, Hans, Victor Guanowsky, Yann S. Mineur, et al.. (2009). Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect. European Journal of Pharmacology. 605(1-3). 114–116. 76 indexed citations
7.
Rollema, Hans, Alka Shrikhande, Karen Ward, et al.. (2009). Preclinical properties of the α4β2 nAChR partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. Biochemical Pharmacology. 78(7). 918–919. 5 indexed citations
8.
O’Donnell, Christopher J., Brian T. O’Neill, Eric P. Arnold, et al.. (2009). Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates – subtype selective, high affinity α7 nicotinic acetylcholine receptor agonists. Bioorganic & Medicinal Chemistry Letters. 19(16). 4747–4751. 11 indexed citations
9.
Shrikhande, Alka, et al.. (2007). Hematological profile of sickle cell disease in central India. Indian Journal of Hematology and Blood Transfusion. 23(3-4). 92–98. 16 indexed citations
10.
Shrikhande, Alka, et al.. (2007). Double heterozygous for hemoglobin S and hemoglobin E — a case report from central India. Indian Journal of Hematology and Blood Transfusion. 23(3-4). 119–121. 8 indexed citations
11.
Siuciak, Judith A., Douglas S. Chapin, John F. Harms, et al.. (2006). Inhibition of the striatum-enriched phosphodiesterase PDE10A: A novel approach to the treatment of psychosis. Neuropharmacology. 51(2). 386–396. 226 indexed citations
12.
Menniti, Frank S., Timothy M. Brown, Michael A. Collins, et al.. (2003). Molecular mechanisms for the putative antipsychotic activity of PDE10A inhibitors: PDE10A regulation of intracellular signaling in striatal medium spiny neurons in culture. Schizophrenia Research. 60(1). 313–314. 3 indexed citations
13.
Shrikhande, Alka, et al.. (2002). Fully Automated Radioligand Binding Filtration Assay for Membrane-Bound Receptors. BioTechniques. 33(4). 932–937. 1 indexed citations
14.
Dumas, Jacques, Robert Sibley, Bernd Riedl, et al.. (2000). Discovery of a new class of p38 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(18). 2047–2050. 34 indexed citations
15.
Dumas, Jacques, Holia Hatoum‐Mokdad, Robert Sibley, et al.. (2000). 1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(18). 2051–2054. 47 indexed citations
16.
Shrikhande, Alka, et al.. (1998). A simple screening test for the detection of heterozygous beta thalassemia.. PubMed. 41(4). 423–6. 10 indexed citations
17.
Homandberg, Gene A., et al.. (1997). Cartilage chondrolysis by fibronectin fragments causes cleavage of aggrecan at the same site as found in osteoarthritic cartilage. Osteoarthritis and Cartilage. 5(6). 450–453. 34 indexed citations
18.
Pande, Sushil, et al.. (1997). Immunochemical studies in multiple myeloma.. PubMed. 34(4). 151–8. 2 indexed citations
19.
Janis, Ronald A., Alka Shrikhande, D. E. Johnson, et al.. (1988). Isolation and characterization of a fraction from brain that inhibits 1,4‐[3H]dihydropyridine binding and L‐type calcium channel current. FEBS Letters. 239(2). 233–236. 14 indexed citations
20.
Sarmiento, J. George, Alka Shrikhande, Ronald A. Janis, & D. J. Triggle. (1987). [3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes.. Journal of Pharmacology and Experimental Therapeutics. 241(1). 140–146. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terri Cummons Breakdown of academic impact, for papers by Lucien Gazi Breakdown of academic impact, for papers by Jason P. Riley Breakdown of academic impact, for papers by Rhonda L. Carter Breakdown of academic impact, for papers by P.A. Robson Breakdown of academic impact, for papers by Boonlert Cheewatrakoolpong Breakdown of academic impact, for papers by Masahito Ogasawara Breakdown of academic impact, for papers by Marina Stolina Breakdown of academic impact, for papers by Minh Vu Chuong Nguyen Breakdown of academic impact, for papers by Naj Sharif
Rankless by CCL
2026